Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
New Bioethics is Scopus-indexed (Q2, CiteScore 3.6), WoS ESCI. It is covered by India's One Nation One Subscription scheme for reading access. Published by Maney Publishing.
Checked against the index lists dated .
ISSN 2050-2877Verify ISSN ↗2050-2885Verify ISSN ↗
Publisher: Maney Publishing
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Issues, Ethics and Legal Aspects | 18 / 53 | 66th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2012–present, best quartile Q2, CiteScore 3.6.
New Bioethics is Q2 in Issues, Ethics and Legal Aspects (rank 18 of 53), by CiteScore 2025.
New Bioethics is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.6, which places it in quartile Q2 at the 66th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.359, quartile Q3, with an H-index of 19.
New Bioethics is published by Maney Publishing. Its print ISSN is 2050-2877 and its online ISSN is 2050-2885.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
New Bioethics has an h-index of 26 and a 2-year mean of 0.98 citations per paper (OpenAlex). Its Scopus CiteScore is 3.6, quartile Q2. On 2-year citations it ranks #32 of 53 Scopus journals in Issues, Ethics and Legal Aspects.
New Bioethics published 13 papers in 2025; its busiest recent year was 2022 with 55. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 93 research articles (2021–2026), authors are most often from United Kingdom (37.6%), United States (26.9%) and Australia (5.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.